Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF.

scientific article published on 03 September 2013

Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.00919-13
P932PMC publication ID3811841
P698PubMed publication ID24002059

P50authorSusan M EganQ38318359
Veerendra KoppoluQ59146862
P2093author name stringP Scott Hefty
Jeff M Skredenske
Jiaqin Li
Ichie Osaka
Bria Kettle
P2860cites workNeural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneriQ24533240
Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphologyQ24534908
Allostery in the LacI/GalR family: variations on a themeQ24653579
Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motilityQ24683572
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosisQ27679180
Structure and composition of the Shigella flexneri "needle complex", a part of its type III secretonQ28199735
IpaB mediates macrophage apoptosis induced by Shigella flexneriQ28254424
The AraC family transcriptional regulator Rv1931c plays a role in the virulence of Mycobacterium tuberculosisQ28486737
A bacterial invasin induces macrophage apoptosis by binding directly to ICEQ28512900
Arac/XylS family of transcriptional regulatorsQ28776772
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stabilityQ29547634
Thermofluor-based high-throughput stability optimization of proteins for structural studiesQ29614747
High-density miniaturized thermal shift assays as a general strategy for drug discoveryQ29618133
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidatesQ31037921
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discoveryQ33205643
Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analysesQ33279723
High-throughput screening of the virulence regulator VirF: a novel antibacterial target for shigellosisQ33541815
The AraC/XylS family activator RhaS negatively autoregulates rhaSR expression by preventing cyclic AMP receptor protein activationQ33558066
Characterization of the Shigella flexneri ipgD and ipgF genes, which are located in the proximal part of the mxi locusQ33594863
Global burden of Shigella infections: implications for vaccine development and implementation of control strategiesQ33749510
The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranesQ33878820
Amino acid-DNA contacts by RhaS: an AraC family transcription activatorQ33992786
Antibiotic overuse: Stop the killing of beneficial bacteriaQ34210630
Phylogeny of the bacterial superfamily of Crp-Fnr transcription regulators: exploiting the metabolic spectrum by controlling alternative gene programsQ34279044
VirF-independent regulation of Shigella virB transcription is mediated by the small RNA RyhB.Q34305594
MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion systemQ34316975
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control studyQ34345075
Identification of a small-molecule inhibitor of bacterial AraC family activatorsQ34567886
The future challenges facing the development of new antimicrobial drugs.Q34988239
Exploiting genomics, genetics and chemistry to combat antibiotic resistance.Q35140829
The challenge of multidrug resistance: actual strategies in the development of novel antibacterialsQ35152434
Physical and genetic characterization of the glnA--glnG region of the Escherichia coli chromosomeQ35383570
Shigella flexneri infection: pathogenesis and vaccine development.Q35671854
Antimicrobial resistance among enteric pathogensQ35797361
Fragment-based lead discoveryQ35852295
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaQ36382134
Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.Q36422508
Involvement of a plasmid in the invasive ability of Shigella flexneri.Q36437346
Tsp: a tail-specific protease that selectively degrades proteins with nonpolar C terminiQ36769544
An AraC-type transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island contributes to pathogenesis and intracellular macrophage survivalQ36974415
Late stage antibacterial drugs in the clinical pipelineQ36976704
High throughput methods of assessing protein stability and aggregationQ37395815
Anti-virulence strategies to combat bacteria-mediated diseaseQ37676924
Transcriptional control of the invasion regulatory gene virB of Shigella flexneri: activation by virF and repression by H-NSQ38315694
LUEGO: a cost and time saving gel shift procedureQ38331201
A multifactor regulatory circuit involving H-NS, VirF and an antisense RNA modulates transcription of the virulence gene icsA of Shigella flexneri.Q38333799
A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strainsQ38350074
Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and MuQ39605636
Escape of intracellular Shigella from autophagy requires binding to cholesterol through the type III effector, IcsB.Q39685344
Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by Shigella flexneri 2aQ39928014
A role for H-NS in the thermo-osmotic regulation of virulence gene expression in Shigella flexneriQ39932607
Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a.Q39953337
Spontaneous insertion of an IS1-like element into the virF gene is responsible for avirulence in opaque colonial variants of Shigella flexneri 2a.Q40148576
Molecular cloning of a genetic determinant for Congo red binding ability which is essential for the virulence of Shigella flexneriQ40172273
Role and regulation of the Shigella flexneri sit and MntH systemsQ40252366
Escape of intracellular Shigella from autophagyQ40485419
Rough mutant of Shigella flexneri 2a that penetrates tissue culture cells but does not evoke keratoconjunctivitis in guinea pigsQ40788689
The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD.Q40793797
A system for identifying post-invasion functions of invasion genes: requirements for the Mxi-Spa type III secretion pathway of Shigella flexneri in intercellular disseminationQ40917707
Phylogenetic, structural and functional analyses of the LacI-GalR family of bacterial transcription factorsQ40936125
Shigella actin-based motility in the absence of vinculinQ41139826
Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a.Q41161776
Measurement of invasion by gentamicin resistanceQ41502010
IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuoleQ41524587
HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cellsQ41621201
New strategies for antibacterial drug designQ41627216
Temperature-regulated expression of invasion genes inShigella flexneriis controlled through the transcriptional activation of thevirBgene on the large plasmidQ41689426
Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factorQ41728153
IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cellsQ42206130
The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneriQ42638971
Thermoregulation of Shigella and Escherichia coli EIEC pathogenicity. A temperature-dependent structural transition of DNA modulates accessibility of virF promoter to transcriptional repressor H-NS.Q42662171
Assessment of the Alamar Blue assay for cellular growth and viability in vitroQ42800570
Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trialQ42982958
PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.Q43247716
OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosisQ44091047
Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 yearsQ44310256
The VirF protein from Shigella flexneri is a member of the AraC transcription factor superfamily and is highly homologous to Rns, a positive regulator of virulence genes in enterotoxigenic Escherichia coliQ45048153
PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulenceQ46092317
Inoculum size in shigellosis and implications for expected mode of transmissionQ47172816
Immunity in Shigellosis. I. Response of Man to Attenuated Strains of ShigellaQ54040438
The DNA-binding domain as a functional indicator: the case of the AraC/XylS family of transcription factors.Q54435894
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis.Q54450584
Role of the heat shock protein DnaJ in the lon-dependent degradation of naturally unstable proteins.Q54576552
Leveraging the contribution of thermodynamics in drug discovery with the help of fluorescence-based thermal shift assays.Q54600834
Expression of four virulence antigens of Shigella flexneri is positively regulated at the transcriptional level by the 30 kiloDalton virF protein.Q54742538
pHG165: a pBR322 copy number derivative of pUC8 for cloning and expressionQ70141184
The integration and excision of the bacteriophage lambda genomeQ70974830
Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of Shigella flexneri: the expression of the virF geneQ73486827
Differential regulation of the plasmid-encoded genes in the Shigella flexneri virulence regulonQ73829435
The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanismsQ77179814
A role for H-NS in the regulation of the virF gene of Shigella and enteroinvasive Escherichia coliQ77390615
Neural Wiskott-Aldrich syndrome protein (N-WASP) is the specific ligand for Shigella VirG among the WASP family and determines the host cell type allowing actin-based spreadingQ77936917
An extended role for the nucleoid structuring protein H-NS in the virulence gene regulatory cascade of Shigella flexneriQ78816863
Where will new antibiotics come from?Q79817299
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectShigella flexneriQ1644417
P304page(s)4220-4231
P577publication date2013-09-03
P1433published inInfection and ImmunityQ6029193
P1476titleSmall-molecule inhibitor of the Shigella flexneri master virulence regulator VirF.
P478volume81

Reverse relations

cites work (P2860)
Q342224133-Substituted Biquinolinium Inhibitors of AraC Family Transcriptional Activator VirF from S. flexneri Obtained Through In Situ Chemical Ionization of 3,4-Disubstituted Dihydroquinolines
Q38760476Anti-virulence Strategies to Target Bacterial Infections
Q38366322Approaches targeting the type III secretion system to treat or prevent bacterial infections
Q35187657Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors.
Q40076724Control of Virulence Gene Expression by the Master Regulator, CfaD, in the Prototypical Enterotoxigenic Escherichia coli Strain, H10407.
Q28547782Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF
Q46277703Molecular typing and occurrence of beta-lactam resistance genes of Shigella sonnei strains isolated during 1983-2014 in the São Paulo State in Brazil
Q35600602Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth
Q90170341On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome
Q39173330Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs
Q30580404Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri
Q30832528Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators
Q26738634Role of Escherichia coli in Biofuel Production
Q39381958Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection
Q28072947The Multifaceted Activity of the VirF Regulatory Protein in the Shigella Lifestyle
Q42328253The bacterial type III secretion system as a target for developing new antibiotics
Q41950223VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation
Q38160781Virulence regulons of enterotoxigenic Escherichia coli.
Q50020968Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options.

Search more.